Table 1.
Effects of multipotent mesenchymal stromal cells at “thin” endometrium and Asherman’s syndrome.
Authors | Type of MMSC | Model | Results | References |
---|---|---|---|---|
Kilic, S. et al. | MMSCs from the bone marrow and umbilical cord | Rat model of AS | Increased endometrial vascularization and decreased fibrosis | [74] |
Pekarev, O.G. et al. | Human umbilical cord MSC | Rat model of a uterine scar | Stimulating effect on vascular remodeling and the formation of de novo formed vessels in the uterine scar | [75] |
Zhu, H. et al. | Menstrual stem cells | In vitro | Increased proliferation of endometrial stromal cells, suppression of myofibroblast differentiation | [77] |
Zhao, J. et al. | Autologous bone marrow derived MSC | Rat model of “thin” endometrium | Increased the ET, activated the expression of markers of regeneration and receptivity, anti-inflammatory effects | [78] |
Tan, J. et al. | Autologous menstrual blood-derived stromal cells | Patient’s with severe AS | Increased the ET (71%), pregnancy (71%), live birth (29%) | [81] |
Zhao, Y. et al. | Autologous bone marrow derived MSC | Patient’s with intrauterine adhesions | Restoration of the endometrium in a woman with refractory AS | [80] |
Cao, Y. et al. | Umbilical cord MSCs on collagen scaffolds | Patients with Recurrent Uterine Adhesions | Increased in the ET (100%), pregnancy (38%) | [84] |
Zhang, Y. et al. | Umbilical cord MSC on collagen scaffolds | Patients with AS | Increase in ET (100%), pregnancy (31%), live birth (12%) | [85] |